THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
Sign up for the IMI 2 - Call 5 webinars
Webinars on all IMI2 - Call 5 topics plus IMI's rules and procedures will be held from 1 to 14 July inclusive.
The full schedule and registration information can be found on the webinar page.
- 30/06/2015 : RT @RigaHealth15: “That’s what’s happening now: companies are pooling their knowledge” @EFPIA Richard Bergstrom speaks about @IMI_JU and co…
- 30/06/2015 : IMI project news: join @SafeSciMET in Vienna end September for course on mutagenesis and #carcinogenesis. Info at http://t.co/EQm0MrSpB3
- 30/06/2015 : RT @eupatients: Course Committee meeting in BRU. Planning the 2nd F2F meeting in BCN - It will be a thrill. #patientsinvolved http://t.co/9…